Oncology & Cancer

Tailoring treatment for triple-negative breast cancer

Immunotherapies have revolutionized treatment for people with a variety of cancers. But when given to those with triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, less than 20% respond.

page 1 from 19